Skip to content
Contact Us
Contact Us

1 (609) 860-1300

The image shows the logo of Porton, featuring blue text with an orange star and arc design.The image shows the logo of Porton, featuring blue text with an orange star and arc design.
  • About
    • About J-STAR Research
      • Facilities
      • Visitor Information
    • About Porton
    • Careers
      • Welcome to our Employment section
      • Diversity and Inclusion
      • CA Job Applicant Notice
      • CA Employee Notice
  • DS & DP Capabilities
    • Process R&D/Drug Substance
      • Synthetic Route Design
      • High-Throughput Experimentation (HTE)
      • High Pressure Chemistry Capabilities
      • Continuous Flow Capabilities
      • Statistics & Design of Experiments (DoE)
      • PAT & Reaction Kinetics
    • High Potent Compound & Controlled Substances
      • Controlled Substances (DEA Schedule II-V)
      • Potent & HPAPI Compound Development
      • ADC Payload & Linker
    • Crystallization R&D
      • Solid Form Screening & Selection
      • Single Crystal Structure Elucidation
      • Crystallization Process Development
    • Drug Product
      • Technology Demonstration & Feasibility
      • Pre-Formulation Evaluations
      • Phase 1 Clinical Supply and Support Services
      • Phase 2 & 3 Drug Product Development
    • Analytical R&D and QC
      • Method Development & Forced Degradation
      • Method Validation & Verification
      • Reference Standard Certification
      • Impurity Isolation & Structural Elucidation
      • Genotoxic Impurities
      • ICH Stability Studies
  • Technology Solutions
    • Particle Engineering & Co-Processing
    • Computational Chemistry & Data Science Capabilities
      • Predicting Molecular Properties via Computational Chemistry
      • Computational Chemistry and Data Science Approaches for Pharmaceutical Development
    • Catalysis & Enabling Technology
  • News & Events
    • Company News
    • Tradeshows & Conferences
    • Resources
  • Contact Us
Search
The image shows the logo of Porton, featuring blue text with an orange star and arc design.The image shows the logo of Porton, featuring blue text with an orange star and arc design.
  • About J-STAR Research
    • About Porton
    • Careers
      • CA Employee Notice
      • CA Job Applicant Notice
      • Diversity and Inclusion
      • FOR CALIFORNIA RESIDENTS: DO NOT SELL OR SHARE MY INFORMATION
      • Jobs
      • Welcome to our Employment section
    • Facilities
    • Visitor Information
  • cGMP Intermediate & API Production
    • cGMP Quality Assurance
  • Contact Us
  • Delivering Small Molecules to the Clinic Faster – One Stop CMC
    • J-STAR Research, Inc. Privacy Policy
  • DS & DP Capabilities
    • Analytical R&D and Quality Control
      • Genotoxic Impurities
      • ICH Stability Studies
      • Impurity Isolation & Structural Elucidation
      • Method Development & Forced Degradation
      • Method Validation & Verification
      • Reference Standard Certification
    • Crystallization R&D
      • Crystallization Process Development
      • Single Crystal Structure Elucidation
      • Solid Form Screening & Selection
    • Drug Product
      • Phase 1 Clinical Supply and Support Services
      • Phase 2 & 3 Drug Product Development and Troubleshooting
      • Pre-Formulation Evaluations
      • Technology Demonstration and Feasibility
    • High Potent Compound & Controlled Substances
      • ADC Payload & Linker
      • Controlled Substances (DEA Schedule II-V)
      • Potent & HPAPI Compound Development
    • Process R&D/Drug Substance
      • Continuous Flow Capabilities
      • High Pressure Chemistry Capabilities
      • High-Throughput Experimentation (HTE)
      • Process Analytic Technologies (PAT) & Reaction Kinetics
      • Statistics & Design of Experiments (DoE)
      • Synthetic Route Design
  • Resources
  • Resources: Search Results
  • Technology Solutions
    • Catalysis & Enabling Technology
    • Computational Chemistry & Data Science Capabilities
      • Computational Chemistry and Data Science Approaches for Pharmaceutical Development
      • Predicting Molecular Properties via Computational Chemistry
    • Particle Engineering & Co-Processing

Recent News

  • Two people shaking hands with the text "Porton Aojin" and a handshake icon in between, symbolizing a strategic collaboration.Porton Pharma and Aojin Life Sciences Form Strateg…
    December 11, 2024
  • The building exterior showcases a landscaped garden, reflecting Porton's commitment to sustainable development, with a prominent sign displaying "PORTON" in large letters.Porton Recognized for Sustainable Development in C…
    December 6, 2024
  • A laptop and smartphone display the redesigned website of Porton Pharma Solutions, featuring scientific visuals, information about CDMO services, and a global presence map.Porton Pharma Solutions Launches Newly Redesigned …
    December 6, 2024
  • Five men in business attire stand behind a ribbon labeled "PORTON" at an Investment Forum event. Slovenian officials mingle among blue and white balloons in the background.Porton Attends China-Slovenia Business Forum and M…
    November 13, 2024
  • A group of six people in suits stands behind a display table with "PORTON" and Chinese text, giving thumbs up at a company event celebrating the modality capacity upgrade.Ceremony Marks Porton’s New Modality Capacit…
    November 9, 2024

Upcoming Events

May 20
May 20 - May 22

CPHI North America 2025

Oct 28
October 28 - October 30

CPHI Europe 2025

View Calendar

About

  • About J-STAR Research
  • Facilities
  • Visitor Information
  • About Porton
  • Careers

Analytical R&D

  • Analytical R&D and Quality Control
  • Method Development & Forced Degradation
  • Method Validation & Verification
  • Reference Standard Certification
  • Impurity Isolation & Structural Elucidation
  • Genotoxic Impurities
  • ICH Stability Studies

Chemistry Process R&D

  • Process R&D/Drug Substance
  • Synthetic Route Design
  • High-Throughput Experimentation (HTE)
  • High Pressure Chemistry Capabilities
  • Continuous Flow Capabilities
  • Statistics & Design of Experiments (DoE)
  • Process Analytic Technologies (PAT) & Reaction Kinetics

Crystallization R&D

  • Crystallization R&D
  • Solid Form Screening & Selection
  • Single Crystal Structure Elucidation
  • Crystallization Process Development

Drug Product

  • Drug Product
  • Technology Demonstration and Feasibility
  • Pre-Formulation Evaluations
  • Phase 1 Clinical Supply and Support Services
  • Phase 2 & 3 Drug Product Development and Troubleshooting

Technology Solutions

  • Technology Solutions
  • Particle Engineering & Co-Processing
  • Computational Chemistry & Data Science Capabilities
    • Predicting Molecular Properties via Computational Chemistry
    • Computational Chemistry and Data Science Approaches for Pharmaceutical Development
  • Catalysis & Enabling Technology

High Potent & Controlled Substances

  • High Potent Compound & Controlled Substances
  • Controlled Substances (DEA Schedule II-V)
  • Potent & HPAPI Compound Development
  • ADC Payload & Linker

Resources

  • Brochures
  • Posters
  • Reports
  • Tech Bulletins
  • Videos
  • White Papers

Whitepapers

Molecular Modeling and Data Science for De-risking and Costsaving of Pharmaceutical Development

January 20, 2025
…
Blue outlined document icon with three lines of text on a curved white background. "Whitepaper" is written in orange below.

Enabling Technology II. Dry Particle Coating for the Enhancement of Flowability and Bulk Density

November 11, 2020
…
Blue outlined document icon with three lines of text on a curved white background. "Whitepaper" is written in orange below.

Enabling Technology I. Co-Precipitation Technology (CPT) for the Enhancement of Flowability and Bulk Density

November 11, 2020
…

About
DS & DP Capabilities
Technology Solutions
News

Become part of J-STAR's community to access personalized insights and resources.

By clicking "Submit" you agree to the terms & conditions set forth on the J-STAR Research Privacy Policy page.

ⓒ 2025 J-STAR Research, Inc., a subsidiary of Porton Pharma Solutions, Ltd. This website contains information intended for a broad audience and may include details or information which are not accessible or valid in your country. We accept no responsibility for information which may not comply with legal processes, regulations, registration, or usage in your country of origin.